Published in Neurology on December 01, 1991
An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet (2006) 2.23
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Spinal and cutaneous schwannomatosis is a variant form of type 2 neurofibromatosis: a clinical and molecular study. J Neurol Neurosurg Psychiatry (1997) 1.26
Neurofibromatosis type 1-associated tumours: their somatic mutational spectrum and pathogenesis. Hum Genomics (2011) 1.17
The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics (2009) 1.02
A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet (1998) 0.83
Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet (1997) 0.83
Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion. Neurogenetics (2011) 0.83
Surgical strategies for managing foraminal nerve sheath tumors: the emerging role of CyberKnife ablation. Eur Spine J (2009) 0.80
Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene. Am J Hum Genet (2001) 0.78
Extensive morphea profunda with autoantibodies and benign tumors: A rare case report. Indian Dermatol Online J (2012) 0.75
Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature (2001) 10.96
Von Recklinghausen neurofibromatosis. N Engl J Med (1981) 7.69
Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (1987) 5.11
Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med (1981) 4.25
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet (1996) 4.16
Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A (1995) 3.89
ASHG activities relative to education: Human genetics as a component of medical school curricula: A report to the American society of human genetics. Am J Hum Genet (1988) 3.24
A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet (2004) 3.05
Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics (1978) 3.04
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
Chromosome 15 abnormalities and the Prader-Willi syndrome: a follow-up report of 40 cases. Am J Hum Genet (1982) 2.44
Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer (1982) 2.43
DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system. Hum Mol Genet (1998) 2.24
Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet (1979) 2.18
Specific cloning of human DNA as yeast artificial chromosomes by transformation-associated recombination. Proc Natl Acad Sci U S A (1996) 1.86
Isolation and characterization of the human MRE11 homologue. Genomics (1995) 1.83
Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem (1985) 1.79
Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet (2000) 1.76
Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet (1997) 1.74
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Familial retinoblastoma and chromosome 13 deletion transmitted via an insertional translocation. Science (1981) 1.70
Report of the Task Force on Teaching Human Genetics in North American Medical Schools. Am J Hum Genet (1989) 1.65
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Bridging cognition, the brain and molecular genetics: evidence from Williams syndrome. Trends Neurosci (1999) 1.62
The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations. Am J Med Genet (1984) 1.60
Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res (1997) 1.59
Is it Williams syndrome? GTF2IRD1 implicated in visual-spatial construction and GTF2I in sociability revealed by high resolution arrays. Am J Med Genet A (2009) 1.57
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology (1981) 1.55
Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med (2001) 1.49
APP-BP1, a novel protein that binds to the carboxyl-terminal region of the amyloid precursor protein. J Biol Chem (1996) 1.46
Base ratio, DNA content, and quinacrine-brightness of human chromosomes. Proc Natl Acad Sci U S A (1978) 1.43
Cloning of human cDNAs encoding mitochondrial and cytosolic serine hydroxymethyltransferases and chromosomal localization. J Biol Chem (1993) 1.42
Evolution of the mammalian G protein alpha subunit multigene family. Nat Genet (1992) 1.41
Skin, blood, nerve cells, and heritability. New lessons from neurofibromatosis type 1. Arch Dermatol (1995) 1.40
Health care and disease prevention through genetic counseling: a regional approach. Am J Public Health (1976) 1.37
Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32
von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology (1984) 1.32
A bacterial artificial chromosome-based framework contig map of human chromosome 22q. Proc Natl Acad Sci U S A (1996) 1.30
Giemsa technique for the detection of sister chromatid exchanges. Chromosoma (1974) 1.29
Angiogenic and invasive properties of neurofibroma Schwann cells. J Cell Biol (1990) 1.28
The FG syndrome: further characterization, report of a third family, and of a sporadic case. Am J Med Genet (1977) 1.27
Gene dose effect: intraband mapping of the LDH A locus using cells from four individuals with different interstitial deletions of 11p. Cytogenet Cell Genet (1977) 1.27
Neurofibromatosis: variable expression is not intrinsic to the mutant gene. Birth Defects Orig Artic Ser (1979) 1.26
Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med (1985) 1.26
Oculocutaneous albinoidism as a manifestation of reduced neural crest derivatives in the Prader-Willi syndrome. Am J Ophthalmol (1982) 1.22
Neurofibromatosis: past, present, and future. N Engl J Med (1991) 1.21
Mast-cell stabilization to decrease neurofibroma growth. Preliminary experience with ketotifen. Arch Dermatol (1987) 1.18
Long range physical map of the Wilms' tumor-aniridia region on human chromosome 11. Cell (1988) 1.18
Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3. Hum Mol Genet (1995) 1.17
The human lumican gene. Organization, chromosomal location, and expression in articular cartilage. J Biol Chem (1995) 1.16
Preventive medicine through genetic counseling: a regional program. Prev Med (1975) 1.15
Neurofibromatosis: oral and radiographic manifestations. Oral Surg Oral Med Oral Pathol (1984) 1.15
Trisomy 8: an international study of 70 patients. Birth Defects Orig Artic Ser (1977) 1.13
Use of a fluorescent-PCR reaction to detect genomic sequence copy number and transcriptional abundance. Genome Res (1996) 1.12
A comprehensive large-insert yeast artificial chromosome library for physical mapping of the mouse genome. Mamm Genome (1996) 1.11
Genetic mechanisms of tumor-specific loss of 11p DNA sequences in Wilms tumor. Am J Hum Genet (1987) 1.10
Parental origin of de novo constitutional deletions of chromosomal band 11p13. Am J Hum Genet (1990) 1.10
Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet (1992) 1.09
Protocols to establish genotype-phenotype correlations in Down syndrome. Am J Hum Genet (1991) 1.08
Neurofibromatosis: a neoplastic birth defect with two age peaks of severe problems. Birth Defects Orig Artic Ser (1977) 1.07
Delineation of the common critical region in Williams syndrome and clinical correlation of growth, heart defects, ethnicity, and parental origin. Am J Med Genet (1998) 1.06
Linkage studies with chromosome 17 DNA markers in 45 neurofibromatosis 1 families. Genomics (1987) 1.05
Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells. Birth Defects Orig Artic Ser (1981) 1.04
Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1) Am J Hum Genet (1993) 1.03
Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol (1999) 1.03
Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet (1992) 1.03
Genetic mosaicism in normal tissues of Wilms' tumour patients. Nat Genet (1993) 1.02
Aniridia caused by a heritable chromosome 11 deletion. Ophthalmology (1979) 1.02
Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet (1982) 1.01
Chromosome translocations in couples with multiple spontaneous abortions. Am J Hum Genet (1982) 1.01
De novo 13q paracentric inversion in a boy with cleft palate and mental retardation. Hum Genet (1979) 1.01
Discounting an adverse maternal effect on severity of neurofibromatosis. Pediatrics (1987) 1.00
A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. Am J Hum Genet (1993) 1.00
Partial triplication and deletion of 13q: study of a family presenting with bilateral retinoblastomas. Clin Genet (1979) 1.00
Spondylohumerofemoral hypoplasia (giant cell chondrodysplasia): a neonatally lethal short-limbed skeletal displasia. Am J Med Genet (1982) 0.99
Variable expressivity in autosomal dominant aniridia by clinical, electrophysiologic, and angiographic criteria. Am J Ophthalmol (1980) 0.99
Associations of clinical features in neurofibromatosis 1 (NF1). Genet Epidemiol (2000) 0.99
Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol (1995) 0.99
Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses. J Clin Endocrinol Metab (1980) 0.98
From amplification to gene in thyroid cancer: a high-resolution mapped bacterial-artificial-chromosome resource for cancer chromosome aberrations guides gene discovery after comparative genome hybridization. Am J Hum Genet (1998) 0.98
Café au lait spots: the pediatrician's perspective. Pediatr Rev (2001) 0.98
Possible misdiagnosis of Krabbe disease. J Pediatr (1976) 0.97
BAC and PAC contigs covering 3.5 Mb of the Down syndrome congenital heart disease region between D21S55 and MX1 on chromosome 21. Genomics (1997) 0.97
Additional association of intra-MHC genes, MICA and D6S273, with Addison's disease. Tissue Antigens (2002) 0.97
Duplication of proximal 15q as a cause of Prader-Willi syndrome. Am J Med Genet (1987) 0.97
Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol (2001) 0.97
Pathophysiology of neurofibromatosis. IV. Dermatologic insights into heterogeneity and pathogenesis. J Am Acad Dermatol (1980) 0.96
Characterization of a highly conserved human homolog to the chicken neural cell surface protein Bravo/Nr-CAM that maps to chromosome band 7q31. Genomics (1996) 0.96
Neurofibromatosis: an overview and new directions in clinical investigations. Adv Neurol (1981) 0.95
The ocular presentation of neurofibromatosis 2. Eye (Lond) (1997) 0.94
Mapping parathyroid hormone, beta-globin, insulin, and LDH-A genes within the human chromosome 11 short arm by spot blotting sorted chromosomes. Hum Genet (1985) 0.94
Absent patellae, mild mental retardation, skeletal and genitourinary anomalies, and C group autosomal mosaicism. J Pediatr (1970) 0.94
Rearrangement of chromosome 15 in the region q11.2----q12 in an individual with obesity syndrome and her normal mother. Am J Med Genet (1990) 0.94
Identification and analysis of the human and murine putative chromatin structure regulator SUPT6H and Supt6h. Genomics (1996) 0.93
The gene organization, chromosome location, and expression of a 55-kDa matrix protein (PRELP) of human articular cartilage. Genomics (1996) 0.92
Involvement of protein kinase Cepsilon (PKCepsilon) in thyroid cell death. A truncated chimeric PKCepsilon cloned from a thyroid cancer cell line protects thyroid cells from apoptosis. J Biol Chem (1999) 0.91
Karyotype-phenotype correlation: mosaic trisomy 8 and partial trisomies of different segments of chromosome 8. Hum Genet (1978) 0.91
Genetic analysis of eight loci tightly linked to neurofibromatosis 1. Am J Hum Genet (1989) 0.91
Neurofibromatosis type 1--an update and review for the primary pediatrician. Clin Pediatr (Phila) (1996) 0.91